Subscribe
24 Oct 2024 11:22 AM
In conversation with Bhavna Kewalramani, Sanofi India and Atul Suri, Alembic Pharmaceuticals.
25 Aug 2026 12:15 PM
25 Aug 2026 11:30 AM
25 Aug 2026 11:26 AM
25 Aug 2026 10:54 AM
31 Jul 2026 8:05 PM
31 Jul 2026 10:35 AM
29 Jul 2026 1:27 PM
22 Jun 2026 6:02 PM